Patient Access to Experimental Drugs
Experimental drugs are being used in treating cancer and other life-threatening diseases in the hopes that effective cures and treatments can be identified. There are however, ethical questions relating to the use of experimental drugs and this work seeks to answer the question that asks whether patients should have access to experimental drugs and to answer why or why they should not have this access.
Experimental Drugs
Experimental drugs have carved inroads to treating cancer patients and most recently; this has been reported in the form of a drug that serves to "neutralize two mechanisms cancers need to survive." (Coghlan, 2012) The new drug is Cabozantinib. This drug is reported by one individual interviewed in this study to have been used by a family member who died while taking the drug for non-small cell carcinoma in the form of lung cancer. When asked the question of how this individual feels about the ethics of the use of this drug which played a part in the death of a family member, the individual stated that she feels that it is not ethically wrong because the drug is now advancing in treating cancer and that was the reason the family member participation in the Mayo Clinic trial of this drug in 2001[footnoteRef:1] however, there are others who disagree with this stance. [1: Anonymous Interviewee 28 Mar 2012]
II. Examination of Ethics in Experimental Drug Use
Ethics are in the form of both 'normative' ethics and 'nonnormative ethics' and it is reported that nonnormative ethics are inclusive of: (1)...
Our semester plans gives you unlimited, unrestricted access to our entire library of resources —writing tools, guides, example essays, tutorials, class notes, and more.
Get Started Now